Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06788548 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial
NCT06788548 · ClinicalTrials.gov record · last posted 2026-08-21

Fluorescence Guided Laparoscopic-Endoscopic Cooperative Sentinel Lymph Node Navigation Surgery Strategy for Early Gastric Cancer（IDEAL Stage 2b）

Study acronym: FLECSS
StatusRecruiting
PhaseNot applicable
Started2024-02-03
View on ClinicalTrials.gov ↗
from the ClinicalTrials.gov record
The main treatment for early gastric cancer (EGC) include endoscopic submucosal dissection (ESD) and radical gastrectomy. However, appropriate treatment for patients who exceed the absolute indications and noncurative resection of ESD remains unestablished. Sentinel node navigation surgery (SNNS) enables limited lymph node resection, thereby facilitating function-preserving gastrectomy (FPG) and improving quality of life (QoL). SNNS seems to be the promising solution according to previous study, however evidence-based medicine was lacking. It is imperative to establish its safety and efficacy in patients with EGC. However, the optimal implementation of FPG remain unclear. Moreover, objective assessment of postoperative functional outcomes,remains limited.

Protocol amendment history 1 change detected by DataLookout

2026-08-22
Primary endpoint(s) modified
Was3 and 5-year disease free survival
Now3-year disease-free survival (DFS) rate
Trial Details
NCT Number NCT06788548
Lead Sponsor Beijing Friendship Hospital
Collaborators: China-Japan Friendship Hospital, Cancer Hospital Chinese Academy of Medical Scienc
Conditions Early Gastric Cancer
Enrollment 312 participants
Start Date 2024-02-03
Primary Completion 2029-11-01 (estimated)
Study Completion 2029-12-30 (estimated)
Updated on ClinicalTrials.gov 2026-08-21